Pulmatrix Inc
F:2PU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pulmatrix Inc
F:2PU
|
US |
|
Trip.com Group Ltd
F:CLVB
|
CN |
|
Antipa Minerals Ltd
ASX:AZY
|
AU |
|
iQ International AG
F:IQL
|
CH |
|
Grail Inc
NASDAQ:GRAL
|
US |
|
B
|
Bicecorp SA
SGO:BICE
|
CL |
|
Corporacion Acciona Energias Renovables SA
F:5BP
|
ES |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
IG Design Group PLC
LSE:IGR
|
UK |
|
D
|
Daya Intiguna Yasa Tbk PT
IDX:MDIY
|
ID |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
Deoleo SA
MAD:OLE
|
ES |
|
S
|
Strategic Minerals PLC
F:24S
|
UK |
|
B
|
Bouvet ASA
XBER:BV4
|
NO |
|
E
|
Epsium Enterprise Ltd
NASDAQ:EPSM
|
MO |
|
Capcom Co Ltd
TSE:9697
|
JP |
|
STINAG Stuttgart Invest AG
F:STG
|
DE |
|
N
|
NameSilo Technologies Corp
CNSX:URL
|
CA |
|
P
|
Pathfinder Ventures Inc
F:RVF
|
CA |
|
bluebird bio Inc
NASDAQ:BLUE
|
US |
|
Clearway Energy Inc
NYSE:CWEN.A
|
US |
Bankruptcy Probability
Pulmatrix Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pulmatrix Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Pulmatrix Inc
NASDAQ:PULM
|
6.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
599.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
238.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
224.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pulmatrix Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pulmatrix Inc has no debt.
You can find a full breakdown on its Balance Sheet.